Connection lost
Server error
Fleminger, Inc. v. U.S. Department of Health & Human Services Case Brief
Why Top Law Students (And Those Aspiring to Be) Use LSD+ Briefs
Let's be real, law school is a marathon. Our exclusive Flash-to-Full case system is designed by Harvard Law School and MIT grads to match your pace: Quick summaries when you're slammed, detailed analysis when you need to go deep. Only LSD+ offers this kind of flexibility to genuinely fit your study flow.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A green tea company challenged an FDA-mandated disclaimer for its cancer-risk health claim. The court upheld the part of the disclaimer quantifying the weak scientific evidence but struck down the part stating the FDA’s disagreement, finding it unconstitutionally negated the entire claim.
Legal Significance: This case illustrates the application of the Central Hudson test to compelled commercial speech, establishing that while the FDA can mandate disclaimers on qualified health claims, a disclaimer cannot be so burdensome as to effectively negate or “swallow” the underlying claim it purports to qualify.
Fleminger, Inc. v. U.S. Department of Health & Human Services Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
Fleminger, Inc., a green tea manufacturer, petitioned the FDA to authorize a health claim linking green tea consumption to a reduced risk of breast and prostate cancer. The FDA reviewed the scientific literature and concluded there was not “significant scientific agreement” (SSA) to support an unqualified claim. However, it found “very limited credible evidence” for a potential link. Fleminger proposed its own qualified health claim with a disclaimer stating, “There is credible evidence supporting this claim although the evidence is limited.” The FDA rejected this language. Citing its interest in preventing consumer deception, the FDA exercised its enforcement discretion to permit the claim only if accompanied by its own mandatory disclaimer: “Green tea may reduce the risk of breast or prostate cancer. FDA does not agree that green tea may reduce that risk because there is very little scientific evidence for the claim.” Fleminger filed suit, alleging the FDA’s mandated disclaimer violated its First Amendment commercial speech rights.
Court Holding & Legal Precedent
Issue: Does an FDA-mandated disclaimer for a qualified health claim violate the First Amendment’s protection of commercial speech when it both quantifies the scientific support as “very little” and states that the “FDA does not agree” with the claim?
The court granted summary judgment in part and denied it in part. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
IRAC Legal Analysis
Complete IRAC Analysis for Higher Grades
IRAC (Issue, Rule, Analysis, Conclusion) is the exact format professors want to see in your exam answers. Our exclusive Flash-to-Full briefs combine holding, analysis, and rule statements formatted to match what A+ students produce in exams. These structured briefs help reinforce the essential legal reasoning patterns expected in law school.
Legal Issue
Does an FDA-mandated disclaimer for a qualified health claim violate the First Amendment’s protection of commercial speech when it both quantifies the scientific support as “very little” and states that the “FDA does not agree” with the claim?
Conclusion
This case reinforces the constitutional limits on compelled speech in the commercial Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
Legal Rule
Government regulation of potentially misleading commercial speech is evaluated under the framework Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiu
Legal Analysis
The court applied the *Central Hudson* test. It first affirmed the FDA's Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
Flash-to-Full Case Opinions
Flash Summary
- The FDA can compel a disclaimer on a qualified health claim